FDA analysis found undeclared active pharmaceutical ingredients in many of these products–and in some cases “prescription drugs in amounts that greatly exceed their maximum recommended dosages,” according to Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. The list includes sibutramine (a controlled substance), rimonabant (a drug not approved for marketing in the United States), phenytoin (an anti-seizure medication), and phenolphthalein (a solution used in chemical experiments and a suspected cancer causing agent). Some of the amounts of active pharmaceutical ingredients far exceeded the FDA-recommended levels, putting consumers’ health at risk. Pretty shocking.